Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.
Alef Multimedia/ Oxfam
Be a lifeline for people in crisis zones.
Your gift can be TRIPLED up to a total of $500,000
